I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 7 studies | 28% ± 8% | |
| microglial cell | 7 studies | 27% ± 9% | |
| glutamatergic neuron | 6 studies | 44% ± 24% | |
| GABAergic neuron | 6 studies | 38% ± 21% | |
| astrocyte | 6 studies | 32% ± 14% | |
| macrophage | 6 studies | 28% ± 9% | |
| adipocyte | 5 studies | 21% ± 4% | |
| oligodendrocyte | 5 studies | 29% ± 7% | |
| myeloid cell | 4 studies | 26% ± 6% | |
| oligodendrocyte precursor cell | 4 studies | 28% ± 11% | |
| dendritic cell | 4 studies | 24% ± 8% | |
| monocyte | 4 studies | 22% ± 6% | |
| interneuron | 4 studies | 43% ± 24% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 17% ± 1% | |
| classical monocyte | 3 studies | 23% ± 5% | |
| non-classical monocyte | 3 studies | 22% ± 8% | |
| epithelial cell | 3 studies | 32% ± 11% | |
| natural killer cell | 3 studies | 17% ± 1% | |
| alveolar macrophage | 3 studies | 28% ± 9% | |
| fibroblast | 3 studies | 20% ± 4% | |
| lymphocyte | 3 studies | 24% ± 7% |
